UCLA researchers awarded $4M to advance immunotherapy treatment for pancreatic cancer

UCLA Urology awarded $6M from CA Department of Health Care Services to serve vulnerable patients with prostate cancer

UCLA’s urology department was awarded $6 million from the California Department of Health Care Services to continue providing care and critical services to underinsured and uninsured Californians diagnosed with prostate cancer.

October 25, 2024

Vol.50 No.40

In Brief

UCLA’s Luca Valle receives $2.1M grant from VA to improve prediction of radiorecurrent prostate cancer outcomes

Luca Valle, assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA, was awarded a $2.1 million grant from the U.S. Department of Veterans Affairs to develop new methods to better understand the clinical scope and biological factors that lead to prostate cancer coming back after radiation therapy.

October 25, 2024

Vol.50 No.40

Clinical Roundup

Study finds common breast cancer treatments may speed aging process

A study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center revealed that common breast cancer treatments, including chemotherapy, radiation, and surgery, may accelerate the biological aging process in breast cancer survivors.

October 11, 2024

Vol.50 No.38

In Brief

UCLA researchers receive $3M NIH grant for CRC screening follow-up in underserved communities

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center were awarded a $3 million grant from NIH to improve follow-up care for colorectal cancer screening in underserved populations.

October 04, 2024

Vol.50 No.37

Clinical Roundup

Imaging technique accurately detects ccRCC

A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, the most common form of kidney cancer.

October 04, 2024

Vol.50 No.37

Clinical Roundup

UCLA investigators develop collection of sarcoma patient-derived organoids for personalized cancer treatments

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to work for each individual patient.

September 27, 2024

Vol.50 No.36

UCLA researchers awarded $4M to advance immunotherapy treatment for pancreatic cancer

YOU MAY BE INTERESTED IN

UCLA Urology awarded $6M from CA Department of Health Care Services to serve vulnerable patients with prostate cancer

UCLA’s Luca Valle receives $2.1M grant from VA to improve prediction of radiorecurrent prostate cancer outcomes

Study finds common breast cancer treatments may speed aging process

UCLA researchers receive $3M NIH grant for CRC screening follow-up in underserved communities

Imaging technique accurately detects ccRCC

UCLA investigators develop collection of sarcoma patient-derived organoids for personalized cancer treatments

Renew today!

Subscriber content

Login